Business
Sinovac vaccine shows up to 97 per cent efficacy in early trials, Bio Farma says – Sydney Morning Herald
Indonesia’s state-owned pharmaceutical company said that interim data on trials it was conducting on vaccines produced by the Chinese company showed up to 97 per…
Jakarta: Indonesia’s state-owned pharmaceutical company Bio Farma said on Tuesday that interim data on trials it was conducting on vaccines produced by the Chinese company Sinovac showed up to 97 per cent efficacy.
“Our clinical trial team found, within one month, that the interim data shows up to 97 per cent for its efficacy,” said Iwan Setiawan, a spokesman for Bio Farma, at a news conference.
Sinovac had said earlier that 97 per cent of healthy adults receiving lower dosage participating in its…
-
Business23 hours agoThese 2 ASX 200 blue-chip stocks just hit new record highs
-
Business23 hours agoDoes Macquarie rate Rio Tinto shares a buy, hold or sell after its big news?
-
Noosa News23 hours agoLeague blocked trades that didn’t benefit expansion clubs claims former AFLW coach Nathan Burke
-
Noosa News23 hours agoBus driver attacker avoids time behind bars but major twist emerges